Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Nutex Health (NUTX) over the last 11 years, with FY2024 value amounting to $16.6 million.

  • Nutex Health's Share-based Compensation rose 56085.0% to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.4 million, marking a year-over-year increase of 1062758.25%. This contributed to the annual value of $16.6 million for FY2024, which is 48374.71% up from last year.
  • According to the latest figures from FY2024, Nutex Health's Share-based Compensation is $16.6 million, which was up 48374.71% from $2.8 million recorded in FY2023.
  • Nutex Health's Share-based Compensation's 5-year high stood at $16.6 million during FY2024, with a 5-year trough of $189581.0 in FY2022.
  • Over the past 5 years, Nutex Health's median Share-based Compensation value was $2.8 million (recorded in 2023), while the average stood at $5.2 million.
  • Per our database at Business Quant, Nutex Health's Share-based Compensation tumbled by 9529.21% in 2022 and then skyrocketed by 139591.52% in 2023.
  • Over the past 5 years, Nutex Health's Share-based Compensation (Annual) stood at $2.6 million in 2020, then surged by 56.59% to $4.0 million in 2021, then crashed by 95.29% to $189581.0 in 2022, then soared by 1395.92% to $2.8 million in 2023, then skyrocketed by 483.75% to $16.6 million in 2024.
  • Its Share-based Compensation stands at $16.6 million for FY2024, versus $2.8 million for FY2023 and $189581.0 for FY2022.